A nanofibrous sheet-based system for linear delivery of nifedipine

Journal of Controlled Release

Volumn 149, Issue 3, 2011, Pages 250-257

  Park, Chun Gwon ^a   Kim, Eunji ^a   Park, Min ^a   Park, Jung Hwan ^b   Choy, Young Bin ^a  

^a Seoul National University   (South Korea)

^b Gachon University College of Medicine   (South Korea)

Author keywords

Drug delivery; Electrospinning; Linear drug release; Nifedipine; Oral drug; Poly (lactic co glycolic acid)

Indexed keywords

BIOCOMPATIBLE POLYMER; DIFFERENT THICKNESS; DRUG DIFFUSION; DRUG RELEASE; ELECTROSPINNING METHOD; IN-VITRO; LAG PHASE; MORPHOLOGICAL STRUCTURES; NIFEDIPINE; ORAL DELIVERY; ORAL DRUG; POLY (LACTIC-CO-GLYCOLIC ACID); POLY VINYL PYRROLIDONE; RELEASE MEDIA; SHEET THICKNESS;

DRUG DELIVERY; ELECTROSPINNING; ESTERS; NANOFIBERS; PYRIDINE;

CARBOXYLIC ACIDS;

BIOMATERIAL; NANOFIBER; NIFEDIPINE; PENETRATION ENHANCING AGENT; POLYGLACTIN; POVIDONE;

ARTICLE; CONTROLLED DRUG RELEASE; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG SOLUBILITY; ELECTROSPINNING; IN VITRO STUDY; LINEAR SYSTEM; NANOFIBROUS SHEET BASED SYSTEM; PH; POROSITY; PRIORITY JOURNAL; TABLET COMPRESSION; TABLET THICKNESS;

ADMINISTRATION, ORAL; DELAYED-ACTION PREPARATIONS; LACTIC ACID; NANOSTRUCTURES; NIFEDIPINE; POLYGLYCOLIC ACID; POROSITY; TABLETS; VASODILATOR AGENTS;

EID: 79951955911     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2010.10.023     Document Type: Article

References (27)

1. H. Gupta, D. Bhandari, A. Sharma, Recent trends in oral drug delivery: a review, Recent Pat. Drug Deliv. Formul. 3 (2009) 162-173.
2. S.V. Sastry, J.R. Nyshadham, J.A. Fix, Recent technological advances in oral drug delivery-a review, Pharm. Sci. Technol. Today 3 (2000) 138-145. (Pubitemid 30195827)
3. P. Colombo, F. Sonvico, G. Colombo, R. Bettini, Novel platforms for oral drug delivery, Pharm. Res. 26 (2009) 601-611.
4. M. Efentakis, C. Peponaki, Formulation study and evaluation of matrix and three-layer tablet sustained drug delivery systems based on carbopols with isosorbite mononitrate, AAPS Pharm Sci Tech 9 (2008) 917-923.
5. M. Efentakis, H. Naseef, M. Vlachou, Two-and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs, Drug Dev. Ind. Pharm. 36 (2010) 903-916.
6. M. Gohel, S. Bariya, Fabrication of triple-layer matrix tablets of venlafaxine hydrochloride using xanthan gum, AAPS Pharm Sci Tech 10 (2009) 624-630.
7. Y. Tang, S. Venkatraman, F. Boey, L. Wang, Sustained release of hydrophobic and hydrophilic drugs from a floating dosage form, Int. J. Pharm. 336 (2007) 159-165.
8. J. Goole, F. Vanderbist, K. Amighi, Development and evaluation of new multiple-unit levodopa sustained-release floating dosage forms, Int. J. Pharm. 334 (2007) 35-41.
9. R. Lucinda-Silva, R. Evangelista, Microspheres of alginate-chitosan containing isoniazid, J. Microencapsul. 20 (2003) 145-152. (Pubitemid 36240610)
10. R. Rastogi, Y. Sultana, M. Aqil, A. Ali, S. Kumar, K. Chuttani, A. Mishra, Alginate microspheres of isoniazid for oral sustained drug delivery, Int. J. Pharm. 334 (2007) 71-77.
11. M. Khan, Recent trends and progress in sustained or controlled oral delivery of some water soluble drugs: morphine salts, diltiazem and captopril, Drug Dev. Ind. Pharm. 21 (1995) 1037-1070.
12. D. Fleisher, C. Li, Y. Zhou, L. Pao, A. Karim, Drug, meal and formulation interactions influencing drug absorption after oral administration: clinical implications, Clin. Pharmacokinet. 36 (1999) 233-254. (Pubitemid 29178760)
13. R. Conley, S.K. Gupta, G. Sathyan, Clinical spectrum of the osmotic-controlled release oral delivery system (OROS*), an advanced oral delivery form, Curr. Med. Res. Opin. 22 (2006) 1879-1892. (Pubitemid 44663390)
14. Q. Liu, R. Fassihi, Zero-order delivery of a highly soluble, low dose drug alfuzosin hydrochloride via gastro-retentive system, Int. J. Pharm. 348 (2008) 27-34. (Pubitemid 350278551)
15. D. Yu, C. Branford-White, Z. Ma, L. Zhu, X. Li, X. Yang, Novel drug delivery devices for providing linear release profiles fabricated by 3DP, Int. J. Pharm. 370 (2009) 160-166.
16. D. Yu, X. Yang, W. Huang, J. Liu, Y. Wang, H. Xu, Tablets with material gradients fabricated by three-dimensional printing, J. Pharm. Sci. 96 (2007) 2446-2456.
17. V. Malaterre, J. Ogorka, N. Loggia, R. Gurny, Oral osmotically driven systems: 30 years of development and clinical use, Eur. J. Pharm. Biopharm. 73 (2009) 311-323.
18. P. Laidler, S.C. Maslin, R.W. Gilhome, What's new in Osmosin and intestinal perforation? Pathol. Res. Pract. 180 (1985) 74.
19. R. Verma, D. Krishna, S. Garg, Formulation aspects in the development of osmotically controlled oral drug delivery systems, J. Control. Release 79 (2002) 7-27.
20. D. Swanson, B. Barclay, P. Wong, F. Theeuwes, Nifedipine gastrointestinal therapeutic system, Am. J. Med. 83 (1987) 3-9.
21. I. Sugimoto, A. Kuchiki, H. Nakagawa, K. Tohgo, S. Kondo, I. Iwane, K. Takahashi, Dissolution and absorption of nipedipine from nifedipine- polyvinylpyrrolidone coprecipitate, Drug Dev. Ind. Pharm. 6 (1980) 137-160.
22. J. Anderson, M. Shive, Biodegradation and biocompatibility of PLA and PLGA microspheres, Adv. Drug Deliv. Rev. 28 (1997) 5-24.
23. B. Inanc, Y. Arslan, S. Seker, A. Elcin, Y. Elcin, Periodontal ligament cellular structures engineered with electrospun poly (DL lactide co glycolide) nanofibrous membrane scaffolds, J. Biomed. Mater. Res. A 90 (2009) 186-195.
24. T.H. Kim, T.G. Park, Critical effect of freezing/freeze-drying on sustained release of FITC-dextran encapsulated within PLGA microspheres, Int. J. Pharm. 271 (2004) 207-214.
25. D. Li, M. Frey, Y. Joo, Characterization of nanofibrous membranes with capillary flow porometry, J. Memb. Sci. 286 (2006) 104-114.
26. A.A. Deshpande, C.T. Rhodes, N.H. Shah, A.W. Malick, Controlled-release drug delivery systems for prolonged gastric residence: an overview, Drug Dev. Ind. Pharm. 22 (1996) 531-539.
27. P.W. Gibson, H.L. Schreuder Gibson, D. Rivin, Electrospun fiber mats: transport properties, AIChE J. 45 (1999) 190-195.